...
首页> 外文期刊>The Journal of biological chemistry >Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth
【24h】

Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth

机译:脂肪酸结合蛋白5和PPARβ/δ是表皮生长因子受体诱导的癌细胞生长的关键介质

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Epidermal growth factors and their receptors (EGFRs) promote breast cancer cell proliferation and can drive tumorigenesis. However, the molecular mechanisms that mediate these effects are incompletely understood. We previously showed that mammary tumor development in the mouse model of breast cancer MMTV-neu, a model characterized by amplification of the EGFR ErbB2 in mammary tissue, correlates with a marked up-regulation of fatty acid-binding protein 5 (FABP5). FABP5 functions to deliver ligands to and enhance the transcriptional activity of the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ), a receptor whose target genes include genes involved in cell growth and survival. We show here that in MCF-7 mammary carcinoma cells, EGFR signaling directly up-regulates the expression of FABP5. The data demonstrate that treatment of these cells with the EGFR ligand heregulin-β1 signals through the ERK and the phophatidylinositol-3-kinase cascades, resulting in activation of the transcription factor NF-κB. In turn, NF-κB induces the expression of FABP5 through two cognate response elements in the promoter of this gene. The observations further demonstrate that FABP5 and PPARβ/δ are critical mediators of the ability of EGFR to enhance cell proliferation, indicating that this transcriptional pathway plays a key role in EGFR-induced tumorigenesis. Additional observations indicate that the expression of FABP5 is down-regulated by the Krüppel-like factor KLF2, suggesting a tumor suppressor activity for this factor.
机译:表皮生长因子及其受体(EGFRS)促进乳腺癌细胞增殖,可以驱动肿瘤发生。然而,介导这些效果的分子机制是不完全理解的。我们以前表明,乳腺癌乳腺癌模型中的乳腺肿瘤发育MMTV-Neu,一种以乳腺组织中的EGFR ErbB2扩增的模型,与脂肪酸结合蛋白5的标记上调相关(Fabp5)。 FABP5的用来将配体递送至并增强核受体过氧化物体增殖物激活受体β/δ(PPARβ/δ)的转录活性,其靶基因包括参与细胞生长和存活的基因。我们在这里展示,在MCF-7乳腺癌细胞中,EGFR信号直线调节FABP5的表达。数据表明,通过ERK和Phophatidylinalyol-3-激酶级联用EGFR配体处理这些细胞的eGFR配体,导致转录因子NF-κB的活化。反过来,NF-κB诱导Fabp5通过该基因的启动子中的两个同源反应元素的表达。该观察结果进一步证明FABP5和PPARβ/δ是EGFR提高细胞增殖能力的关键介质,表明该转录途径在EGFR诱导的肿瘤发生中起着关键作用。额外的观察结果表明Fabp5的表达由Krüppel样因子KLF2下调,表明该因素的肿瘤抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号